Jolanta Kunikowska
机构: Nuclear Medicine Department, Medical University of Warsaw
每年引用次数
引用次数
引用: 3,347
H-指数: 30
I10-指数 : 63
出版物: 267
Obrazowanie struktury i czynności narządów wewnętrznych metodą PET : podstawy fizyczne
J. Kunikowska , L. Królicki , A. Bajera
Inżynier i Fizyk Medyczny 1
2012
Diagnostic Accuracy of Contrast-Enhanced Computed Tomography and Positron Emission Tomography With 18-FDG in Identifying Malignant Solitary Pulmonary Nodules
M. Dabrowska , R. Krenke , P. Korczynski , M. Maskey-Warzechowska
Medicine 94 ( 15)
15
2015
Recurrent glioblastoma multiforme – targeted alpha therapy with 213Bi-DOTA-Substance P
L. Krolicki , B. Królicki , A. Morgenstern , J. Kunikowska
Radiotherapy and Oncology 118
2016
Response to comment by Aprile et al.: The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer
F. Giammarile , N. Alazraki , J. N. Aarsvold , R. A. Audisio
European Journal of Nuclear Medicine and Molecular Imaging 41 ( 6) 1259 -1260
3
2014
Glioma tumors grade II/III - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
Constantinos CA Apostolidis , Frank FB Bruchertseifer , Leszek LK Krolicki , Alfred AM Morgenstern
Endocrine Abstracts 47
2016
GUIDELINES FOR PET/CT IMAGING OF NEUROENDOCRINE NEOPLASMS WITH 68Ga-DOTA-SOMATOSTATIN ANALOGUES AND 18F-DOPA.
Murat Fani BOZKURT , Irene VIRGOLINI , Sona BALOGOVA , Mohsen BEHESHTI
Locoregional Treatment of Glioblastoma With Targeted αlpha Therapy [213Bi] Bi-DOTA–Substance P Versus [225Ac] Ac-DOTA–Substance P—Analysis of Influence Parameters
Leszek KROLICKI , Jolanta KUNIKOWSKA , Frank BRUCHERTSEIFER , Radoslaw KULINSKI
Glioblastoma Therapy with Substance P labelled with Bismuth-213
Leszek KROLICKI , Jolanta KUNIKOWSKA , H KOZIARA , Alfred MORGENSTERN
68Ga-DOTA-Substance-P as a Tool for Diagnostics and Locoregional Administration Follow up of 213Bi-DOTA-Substance-P in the Course of Glioma Therapy
Dariusz PAWLAK , Piotr GARNUSZEK , Michal MAURIN , Leszek KROLICKI
Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance P
Alfred MORGENSTERN , Leszek KROLICKI , Jolanta KUNIKOWSKA , H Koziara
X. Znaczenie pozytonowej tomografii emisyjnej (PET) w diagnostyce schorzeń onkologicznych
Leszek KróLICKI , Jolanta KuNIKOWSKA , Małgorzata KOBYLECKA , Joanna MąCZEWSKA
PODSTAWY ONKOLOGII KLINICZNEJ 65 -65
9
2011
Usefulness of PET/CT investigations with 68Ga-DOTATATE in neuroendocrine tumors in diagnosis of primary tumors
Jolanta Kunikowska , Leszek Krolicki , Laretta Grabowska-Derlatka , Malgorzata Kobylecka
The Journal of Nuclear Medicine 52 1355 -1355
2011
Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Side-effects and response to the radioisotope 90Y-DOTA-TATE or 90Y/177Lu DOTA-TATE therapy in patients with disseminated NET
Malgorzata Trofimiuk , Jolanta Kunikowska , Monika Tomaszuk , Leszek Krolicki
Society of Nuclear Medicine Annual Meeting Abstracts 52 300
2011
A semi-quantitative analysis of pathological 68Ga-DOTATATE PET/CT uptake by primary site dependent neuroendocrine tumor metastases
Jolanta Kunikowska , Leszek Królicki , Dariusz Pawlak , Anna Kolasa
The Journal of Nuclear Medicine 54 1929 -1929
2013
Clinical results of PRRT with 90Y-DOTATATE and 90Y/177Lu-DOTATATE - What is better for therapy?
Jolanta Kunikowska , Leszek Krolicki , Malgorzata Kobylecka , Anna Sowa-Staszczak
Society of Nuclear Medicine Annual Meeting Abstracts 50 106
3
2009
Positron emission tomography (PET) in diagnosis of oncological diseases
Jolanta Kunikowska , Katarzyna Fronczewska , Leszek Królicki , Małgorzata Kobylecka
Postępy Nauk Medycznych
3
2011
Comparison of somatostatin receptor scintigraphy with 99m Tc tectrotide and PET/CT 68Ga-DOTATATE in patients with neuroendocrine tumors
Jolanta Kunikowska , Leszek Krolicki , Dariusz Pawlak , Renata Mikolajczak
The Journal of Nuclear Medicine 54 1886 -1886
2013
Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)
Jolanta Kunikowska , Barbara Jarzab , Teresa Starzyńska , Leszek Królicki
Endokrynologia Polska 59 ( 1) 41 -56
18
2008
Nephrotoxicity after PRRT — still a serious clinical problem? Renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATATE and 90Y/177Lu-DOTATATE
Jolanta Kunikowska , Leszek Królicki , Anna Sowa-Staszczak , Alicja Hubalewska-Dydejczyk
Endokrynologia Polska 64 ( 1) 13 -20
9
2013
Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours.
Agata Jabrocka-Hybel , Malgorzata Trofimiuk , Jolanta Kunikowska , Monika Buziak-Bereza
Endokrynologia Polska 62 ( 5) 392 -400
14
2011